Connected Drug Injection Devices - Adherence with Drug Therapy & Disease Management Protocols a Primary Concern - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/klvxsg/connected_drug) has announced the addition of the "Connected Drug Injection Devices" report to their offering.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.

Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

What You Will Learn:

  • What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
  • What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?
  • What therapeutic areas are the current focus of connected devices?
  • Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations
  • What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?
  • What does the current market for connected drug injection devices look like? What will it look like in 2020?
  • What are the key market drivers for the growth of connected injection devices?

Who Should Read This Report:

Development:

  • Drug Developers
  • Device Suppliers
  • CMOs
  • Components/APIs
  • Testing/Validation
  • Clinical Trial Mgmt

Industry:

  • Pharma Managers
  • Biotech Managers
  • Drug Marketers
  • Industry Strategists
  • Financial Analysts
  • Management
  • Consultants

Market:

  • Clinical Managers
  • Drug Distributors
  • Pharma Regulators
  • FDA Consultants
  • Managed Care Managers

Key Topics Covered:

1. Executive Summary

2. Connected Devices - The Opportunity

3. Connectivity Technologies

4. Connected Devices

5. Wearable Devices

6. Third Party Connectivity Devices

7. Near-term Markets for Connected Injection Devices

8. Market Factors

9. Company Profiles

For more information visit http://www.researchandmarkets.com/research/klvxsg/connected_drug

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables, Needles and Syringes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables, Needles and Syringes